NEWSLETTER
RSS
MOBILE
HELP
Cepheid (CPHD)
SHARE
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Overview
A molecular diagnostics company that develops, manufactures and markets systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.
News Feeds
-
Cepheid gets FDA approval for fast infection test
AP
Sep 29 2008
Press Releases
-
Zacks Analyst Interview Highlights: Cepheid, BioSphere Medical and Immucor Aug-06-2008, 06:00AM EDT
-
BeaconEquity.com Issues Technical Trade Alerts on Market Movers: YHOO, GOOG, DENN, RFMD, TRID, CPHD Jul-30-2008, 09:20AM EDT
-
Cepheid Reports Second Quarter Revenue of $42.1 Million Jul-24-2008, 04:00PM EDT
-
Cepheid Selects Pilgrim Software for Integrated CAPA & Complaints Management Jul-10-2008, 04:27PM EDT
News From Around the Web
News
-
FDA approves Cepheid staph test
(BizJournals)Oct 06 2008 -
Oct 05 2008
-
Oct 03 2008
-
Oct 03 2008
-
Superbug test detects MRSA faster (Health Leaders)Sep 30 2008
-
Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus (Genetic Engineering News)Sep 29 2008
-
Top Pre-Market Analyst Downgrades (CPHD, DRIV, FDRY, MAN, MLM, MPEL, MPS, SMOD, VMC) (24/7 Wall St.)Sep 10 2008
-
ET could 'tickle' stars to create galactic internet (New Scientist)Sep 09 2008
Employees
Number of Employees: 473
Revenue per Employee: $366,870
Top Executives
Laurie King, Senior VP, Divisional
Dr. Peter J. Dailey, Ph.D., Senior VP, Divisional
Michael T. Myhre, Vice President/Controller/Chief Accounting Officer/CFO
Dr.David H. Persing, M.D., Ph.D., Executive VP/Chief Technology Officer/Chief Medical Officer/Director
Joseph H. Smith, Senior VP/Secretary/General Counsel
Humberto Reyes, COO/Executive VP
Robert J. Koska, Divisional Senior VP
Andrew D. Miller, Senior VP
Dr. Russell K. Enns, Ph.D., Divisional Senior VP
Board of Directors
Thomas L. Gutshall, Founder/Chairman of the Board/Director
Mitchell D. Mroz, Director
Dr.David H. Persing, M.D., Ph.D., Executive VP/Chief Technology Officer/Chief Medical Officer/Director
Joseph H. Smith, Senior VP/Secretary/General Counsel
Cristina H. Kepner, Director
Dean O. Morton, Director
Financials
Quarterly
Annual
| Income Statement | 07/2008 | 05/2008 | 02/2008 | 11/2007 |
|---|---|---|---|---|
| Sales | 20.24 Mil. | 22.99 Mil. | 24.75 Mil. | 20.02 Mil. |
| Gross Operating Profit | 21.81 Mil. | 21.85 Mil. | 15.68 Mil. | 16.31 Mil. |
| Operating Income before D & A (EBITDA) | 3.41 Mil. | 261 K. | -5.73 Mil. | -2.92 Mil. |
| Total Income Before Interest Expenses (EBIT) | 973 K. | -2.19 Mil. | -5.67 Mil. | -4.74 Mil. |
| Total Net Income | -7.53 Mil. | -1.85 Mil. | -5.29 Mil. | -4.74 Mil. |
| Basic EPS, Total | -0.13 | -0.03 | -0.1 | -0.09 |
| Diluted EPS, Total | -0.13 | -0.03 | -0.1 | -0.09 |
| BALANCE STATEMENT | 07/2008 | 05/2008 | 02/2008 | 11/2007 |
|---|---|---|---|---|
| Cash and Equivalents | 24.87 Mil. | 20 Mil. | 16.48 Mil. | 8.27 Mil. |
| Total Assets | 75.77 Mil. | 77.48 Mil. | 91.68 Mil. | 91.7 Mil. |
| Total Liabilities | 39.38 Mil. | 39.56 Mil. | 35.57 Mil. | 33.9 Mil. |
| Total Capitalization | 131.4 Mil. | 133.3 Mil. | 126.94 Mil. | 127.2 Mil. |
| Cash Flow | 07/2008 | 05/2008 | 02/2008 | 11/2007 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | 3.97 Mil. | NA | NA | -19.18 Mil. |
| Net Cash From Investing Activities | -4.92 Mil. | NA | NA | 7.87 Mil. |
| Net Cash From Financing Activities | 9.33 Mil. | NA | NA | 2.29 Mil. |
| Net Change in Cash & Cash Equivalents | 8.39 Mil. | NA | NA | -8.92 Mil. |
| Income Statement | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Sales | 81.43 Mil. | 41.07 Mil. | 39.7 Mil. | 23.03 Mil. |
| Gross Operating Profit | 48.04 Mil. | 46.28 Mil. | 45.31 Mil. | 29.94 Mil. |
| Operating Income before D & A (EBITDA) | -24.49 Mil. | -22.4 Mil. | -7.04 Mil. | -9.46 Mil. |
| Total Income Before Interest Expenses (EBIT) | -21.21 Mil. | -25.62 Mil. | -13.59 Mil. | -13.8 Mil. |
| Total Net Income | -21.42 Mil. | -25.98 Mil. | -13.59 Mil. | -13.8 Mil. |
| Basic EPS, Total | -0.39 | -0.5 | -0.32 | -0.34 |
| Diluted EPS, Total | -0.39 | -0.5 | -0.32 | -0.34 |
| BALANCE STATEMENT | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Cash and Equivalents | 16.48 Mil. | 17.19 Mil. | 16.07 Mil. | 23.19 Mil. |
| Total Assets | 91.68 Mil. | 121.81 Mil. | 59.77 Mil. | 78.97 Mil. |
| Total Liabilities | 35.57 Mil. | 31.45 Mil. | 40.21 Mil. | 33.75 Mil. |
| Total Capitalization | 126.94 Mil. | 132.75 Mil. | 57.46 Mil. | 85.96 Mil. |
| Cash Flow | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | -11.7 Mil. | -5.75 Mil. | -6.12 Mil. |
| Net Cash From Investing Activities | NA | -74.82 Mil. | -5.62 Mil. | -52.26 Mil. |
| Net Cash From Financing Activities | NA | 87.68 Mil. | 4.07 Mil. | 63.06 Mil. |
| Net Change in Cash & Cash Equivalents | NA | 1.11 Mil. | -7.12 Mil. | 4.68 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
1.64 Bil.
1.46 Bil.
2.04 Bil.
1.29 Bil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- To request a change please click here
Also in Portfolio.com
Most Read
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.
RSS Most Read
Mobile